130 related articles for article (PubMed ID: 19202550)
41. ERAP1 overexpression in HPV-induced malignancies: A possible novel immune evasion mechanism.
Steinbach A; Winter J; Reuschenbach M; Blatnik R; Klevenz A; Bertrand M; Hoppe S; von Knebel Doeberitz M; Grabowska AK; Riemer AB
Oncoimmunology; 2017; 6(7):e1336594. PubMed ID: 28811980
[TBL] [Abstract][Full Text] [Related]
42. Genome-wide association study of susceptibility loci for cervical cancer.
Chen D; Juko-Pecirep I; Hammer J; Ivansson E; Enroth S; Gustavsson I; Feuk L; Magnusson PK; McKay JD; Wilander E; Gyllensten U
J Natl Cancer Inst; 2013 May; 105(9):624-33. PubMed ID: 23482656
[TBL] [Abstract][Full Text] [Related]
43. Structural and biochemical insights into the association between ERAP1 polymorphism and autoimmune diseases.
Liu S; Lu J; Wu J; Feng D; Wang Y; Su X; Cao H
Biochem Biophys Res Commun; 2022 Dec; 632():189-194. PubMed ID: 36228519
[TBL] [Abstract][Full Text] [Related]
44. Genetic contributions of MHC class I antigen processing and presentation pathway to bladder cancer risk and recurrence.
Wieczorek E; Jablonowski Z; Lesicka M; Jablonska E; Kutwin P; Reszka E; Garstka MA
Neoplasma; 2022 Mar; 69(2):443-455. PubMed ID: 35068162
[TBL] [Abstract][Full Text] [Related]
45. Polymorphisms in ERAP1 and ERAP2 are shared by Caninae and segregate within and between random- and pure-breeds of dogs.
Pedersen NC; Dhanota JK; Liu H
Vet Immunol Immunopathol; 2016 Oct; 179():46-57. PubMed ID: 27590425
[TBL] [Abstract][Full Text] [Related]
46. Systematic investigation of contribution of genetic variation in the HLA-DP region to cervical cancer susceptibility.
Chen D; Gyllensten U
Carcinogenesis; 2014 Aug; 35(8):1765-9. PubMed ID: 24743517
[TBL] [Abstract][Full Text] [Related]
47. Endoplasmic reticulum aminopeptidase-1 mediates leukemia inhibitory factor-induced cell surface human leukocyte antigen-G expression in JEG-3 choriocarcinoma cells.
Shido F; Ito T; Nomura S; Yamamoto E; Sumigama S; Ino K; Itakura A; Hattori A; Tsujimoto M; Mizutani S; Kikkawa F
Endocrinology; 2006 Apr; 147(4):1780-8. PubMed ID: 16439450
[TBL] [Abstract][Full Text] [Related]
48. Degree of predicted minor histocompatibility antigen mismatch correlates with poorer clinical outcomes in nonmyeloablative allogeneic hematopoietic cell transplantation.
Larsen ME; Kornblit B; Larsen MV; Masmas TN; Nielsen M; Thiim M; Garred P; Stryhn A; Lund O; Buus S; Vindelov L
Biol Blood Marrow Transplant; 2010 Oct; 16(10):1370-81. PubMed ID: 20353833
[TBL] [Abstract][Full Text] [Related]
49. HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker.
Ogino T; Shigyo H; Ishii H; Katayama A; Miyokawa N; Harabuchi Y; Ferrone S
Cancer Res; 2006 Sep; 66(18):9281-9. PubMed ID: 16982773
[TBL] [Abstract][Full Text] [Related]
50. Relationship between HLA class I antigen processing machinery component expression and the clinicopathologic characteristics of bladder carcinomas.
Cathro HP; Smolkin ME; Theodorescu D; Jo VY; Ferrone S; Frierson HF
Cancer Immunol Immunother; 2010 Mar; 59(3):465-72. PubMed ID: 19756593
[TBL] [Abstract][Full Text] [Related]
51. Significant effects of lymph and blood vascular invasion on the prognosis of early-stage cervical squamous cell carcinoma.
Zhang Y; Yan M; He J; Sun J; Sun X
J Obstet Gynaecol Res; 2010 Oct; 36(5):1015-22. PubMed ID: 20846259
[TBL] [Abstract][Full Text] [Related]
52. Autoimmune risk variants in ERAP2 are associated with gene-expression levels in thymus.
Gabrielsen IS; Viken MK; Amundsen SS; Helgeland H; Holm K; Flåm ST; Lie BA
Genes Immun; 2016 Dec; 17(7):406-411. PubMed ID: 27829666
[TBL] [Abstract][Full Text] [Related]
53. Functional antigen processing and presentation mechanism as a prerequisite factor of response to treatment with dendritic cell vaccines and anti-PD-1 in preclinical murine LLC1 and GL261 tumor models.
Žilionytė K; Bagdzevičiūtė U; Mlynska A; Urbštaitė E; Paberalė E; Dobrovolskienė N; Krasko JA; Pašukonienė V
Cancer Immunol Immunother; 2022 Nov; 71(11):2691-2700. PubMed ID: 35364740
[TBL] [Abstract][Full Text] [Related]
54. A First Step for the Molecular Characterization of Neurological Involvement of Behçet Syndrome: an Italian Pivotal Study.
Padula MC; Leccese P; Lascaro N; Padula AA; Carbone T; Martelli G; D'Angelo S
J Mol Neurosci; 2021 Jun; 71(6):1284-1289. PubMed ID: 33216288
[TBL] [Abstract][Full Text] [Related]
55. Discovery and Optimization of a Series of Benzofuran Selective ERAP1 Inhibitors: Biochemical and
Deddouche-Grass S; Andouche C; Bärenz F; Halter C; Hohwald A; Lebrun L; Membré N; Morales R; Muzet N; Poirot M; Reynaud M; Roujean V; Weber F; Zimmermann A; Heng R; Basse N
ACS Med Chem Lett; 2021 Jul; 12(7):1137-1142. PubMed ID: 34267884
[TBL] [Abstract][Full Text] [Related]
56. ERAP1 molecular characterization: Identification of a de novo allelic variant.
Padula MC; Leccese P; Padula AA; D'Angelo S; Martelli G
HLA; 2018 Mar; ():. PubMed ID: 29577660
[TBL] [Abstract][Full Text] [Related]
57. No association of TAP1 and TAP2 genes polymorphism with risk of cervical cancer in north Indian population.
Kordi Tamandani DM; Sobti RC; Shekari M; Husseini SA; Suri V
J Assist Reprod Genet; 2009 Apr; 26(4):173-8. PubMed ID: 19263211
[TBL] [Abstract][Full Text] [Related]
58. Additive loss-of-function proteasome subunit mutations in CANDLE/PRAAS patients promote type I IFN production.
Brehm A; Liu Y; Sheikh A; Marrero B; Omoyinmi E; Zhou Q; Montealegre G; Biancotto A; Reinhardt A; Almeida de Jesus A; Pelletier M; Tsai WL; Remmers EF; Kardava L; Hill S; Kim H; Lachmann HJ; Megarbane A; Chae JJ; Brady J; Castillo RD; Brown D; Casano AV; Gao L; Chapelle D; Huang Y; Stone D; Chen Y; Sotzny F; Lee CC; Kastner DL; Torrelo A; Zlotogorski A; Moir S; Gadina M; McCoy P; Wesley R; Rother KI; Hildebrand PW; Brogan P; Krüger E; Aksentijevich I; Goldbach-Mansky R
J Clin Invest; 2015 Nov; 125(11):4196-211. PubMed ID: 26524591
[TBL] [Abstract][Full Text] [Related]
59. PSMB8 (LMP7) but not PSMB9 (LMP2) gene polymorphisms are associated to pigeon breeder's hypersensitivity pneumonitis.
Camarena A; Aquino-Galvez A; Falfán-Valencia R; Sánchez G; Montaño M; Ramos C; Juárez A; García-de-Alba C; Granados J; Selman M
Respir Med; 2010 Jun; 104(6):889-94. PubMed ID: 20153157
[TBL] [Abstract][Full Text] [Related]
60. Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
Bailey SD; Xie C; Do R; Montpetit A; Diaz R; Mohan V; Keavney B; Yusuf S; Gerstein HC; Engert JC; Anand S;
Diabetes Care; 2010 Oct; 33(10):2250-3. PubMed ID: 20628086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
